Indications and uses
cures most athlete's foot (tinea pedis) and ringworm (tinea corporis) helps prevent most athlete's foot from recurring when used daily relieves itching, scaling, cracking, burning, and redness
cures most athlete's foot (tinea pedis) and ringworm (tinea corporis) helps prevent most athlete's foot from recurring when used daily relieves itching, scaling, cracking, burning, and redness
■ shake well before using ■ wash affected area and dry thoroughly ■ apply a thin layer of the product over affected area (around the nails and underneath nail tips) twice daily or as directed by a doctor ■ supervise children in the use of this product ■ for athlete’s foot, pay special attention to spaces between the toes; wear well fitting, ventilated shoes and change shoes and socks at least once daily ■ for athl...
store at room temperature 15º-30ºC (59º-86ºF)
Tolnaftate 1%
Anti-fungal
For external use only
Extremely flammable
If swallowed, get medical help or contact a Poison Control Center right away Keep out of reach of children.
■ shake well before using ■ wash affected area and dry thoroughly ■ apply a thin layer of the product over affected area (around the nails and underneath nail tips) twice daily or as directed by a doctor ■ supervise children in the use of this product ■ for athlete’s foot, pay special attention to spaces between the toes; wear well fitting, ventilated shoes and change shoes and socks at least once daily ■ for athlete’s foot and ringworm, use daily for 4 weeks. If condition persists longer, consult a doctor ■ this product is not effective on the scalp or nails
Acetone, Aloe Vera (Aloe Barbadensis) Gel, Propylene Glycol, Tocopherol Acetate (Vitamin E), Water
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1311221 | ProClearz 1 % Topical Solution | PSN | 38 |
| 313423 | tolnaftate 1 % Topical Solution | PSN | 38 |
| 1311221 | tolnaftate 10 MG/ML Topical Solution [Proclearz] | SBD | 38 |
| 313423 | tolnaftate 10 MG/ML Topical Solution | SCD | 38 |
| 1311221 | Proclearz 1 % Topical Solution | SY | 38 |
| 1311221 | Proclearz 10 MG/ML Topical Solution | SY | 38 |
| 313423 | tolnaftate 1 % Topical Solution | SY | 38 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 29784-181-01 | ProClearzMaximum Strength Fungal Shield Brush-on Antifungal | 30 mL in 1 BOTTLE, WITH APPLICATOR | SOLUTION | 30 | 38 | |
| 29784-181-02 | ProClearzMaximum Strength Fungal Shield Brush-on Antifungal | 1 in 1 BOX | SOLUTION | 1 | 38 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TOLNAFTATE | ACTIVE INGREDIENT | 06KB629TKV | 6 | |
| TOLNAFTATE | ACTIVE MOIETY | 06KB629TKV | 6 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 6 | |
| ACETONE | INACTIVE INGREDIENT | 1364PS73AF | 6 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 6 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 29784-181 | 29784-181-01, 29784-181-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETONE | 1364PS73AF | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| TOLNAFTATE | 06KB629TKV | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 37 | 2026-01-29 | monthly-update | 2026-06-03 17:53:22 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| ACETONE | ACETONE | 1364PS73AF | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| ACETONE | ACETONE | 1364PS73AF | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| ACETONE | ACETONE | 1364PS73AF | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ProClearz Maximum Strength Fungal Shield Brush-on Antifungal | TOLNAFTATE | Rooftop Consumer Health, Inc. | 4d451e87-c25b-49cf-92b8-747b053930c2 | 2026-03-02 | Warnings | 29784-181-02 29784-181-01 29784-181 29784018102 29784018101 4c0c1702-95ab-d4ad-e063-6294a90afb7c 4d451e87-c25b-49cf-92b8-747b053930c2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.